Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 26;17(9):498.
doi: 10.3390/md17090498.

Comparative Genomic Insights into Secondary Metabolism Biosynthetic Gene Cluster Distributions of Marine Streptomyces

Affiliations

Comparative Genomic Insights into Secondary Metabolism Biosynthetic Gene Cluster Distributions of Marine Streptomyces

Lin Xu et al. Mar Drugs. .

Abstract

Bacterial secondary metabolites have huge application potential in multiple industries. Biosynthesis of bacterial secondary metabolites are commonly encoded in a set of genes that are organized in the secondary metabolism biosynthetic gene clusters (SMBGCs). The development of genome sequencing technology facilitates mining bacterial SMBGCs. Marine Streptomyces is a valuable resource of bacterial secondary metabolites. In this study, 87 marine Streptomyces genomes were obtained and carried out into comparative genomic analysis, which revealed their high genetic diversity due to pan-genomes owning 123,302 orthologous clusters. Phylogenomic analysis indicated that the majority of Marine Streptomyces were classified into three clades named Clade I, II, and III, containing 23, 38, and 22 strains, respectively. Genomic annotations revealed that SMBGCs in the genomes of marine Streptomyces ranged from 16 to 84. Statistical analysis pointed out that phylotypes and ecotypes were both associated with SMBGCs distribution patterns. The Clade I and marine sediment-derived Streptomyces harbored more specific SMBGCs, which consisted of several common ones; whereas the Clade II and marine invertebrate-derived Streptomyces have more SMBGCs, acting as more plentiful resources for mining secondary metabolites. This study is beneficial for broadening our knowledge about SMBGC distribution patterns in marine Streptomyces and developing their secondary metabolites in the future.

Keywords: Streptomyces; biosynthetic gene clusters; comparative genomics; ecotype; phylotype; secondary metabolites.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of competing interests.

Figures

Figure 1
Figure 1
Genomic size and gene counts of Streptomyces derived from various marine environments.
Figure 2
Figure 2
Secondary metabolism biosynthetic gene clusters (SMBGC) category counts identified in marine Streptomyces genomes.
Figure 3
Figure 3
Individual and exclusive orthologous clusters (OCs) of marine Streptomyces genomes.
Figure 4
Figure 4
Maximum-likelihood phylogenomic tree based on the concatenation of 888 single-copy OC proteins shared by all of marine Streptomyces. Filled circle indicated nodes showing >85 of bootstrap values. Kitasatospora setae KM-6054 was used as an outgroup.
Figure 5
Figure 5
Heat maps of clade-specific SMBGCs. Dark brown and light brown indicate presence and absence of SMBGCs.
Figure 6
Figure 6
Distribution percentages of ecotype-specific SMBGCs.

References

    1. Sekurova O.N., Schneider O., Zotchev S.B. Novel bioactive natural products from bacteria via bioprospecting, genome mining and metabolic engineering. Microb. Biotechnol. 2019 doi: 10.1111/1751-7915.13398. - DOI - PMC - PubMed
    1. Malik V. Microbial secondary metabolism. Trends Biochem. Sci. 1980;5:68–72. doi: 10.1016/0968-0004(80)90071-7. - DOI
    1. Van der Meij A., Worsley S.F., Hutchings M.I., van Wezel G.P. Chemical ecology of antibiotic production by actinomycetes. FEMS Microbiol. Rev. 2017;41:392–416. doi: 10.1093/femsre/fux005. - DOI - PubMed
    1. Mascuch S., Kubanek J. A marine chemical defense partnership. Science. 2019;364:1034–1035. doi: 10.1126/science.aax8964. - DOI - PubMed
    1. Demain A.L., Sanchez S. Microbial drug discovery: 80 years of progress. J. Antibiot. 2009;62:5–16. doi: 10.1038/ja.2008.16. - DOI - PMC - PubMed

Substances

LinkOut - more resources